Literature DB >> 30243859

Patients' Experience With Opioid Tapering: A Conceptual Model With Recommendations for Clinicians.

Stephen G Henry1, Debora A Paterniti2, Bo Feng3, Ana-Maria Iosif4, Richard L Kravitz5, Gary Weinberg2, Penney Cowan6, Susan Verba7.   

Abstract

Clinical guidelines discourage prescribing opioids for chronic pain, but give minimal advice about how to discuss opioid tapering with patients. We conducted focus groups and interviews involving 21 adults with chronic back or neck pain in different stages of opioid tapering. Transcripts were qualitatively analyzed to characterize patients' tapering experiences, build a conceptual model of these experiences, and identify strategies for promoting productive discussions of opioid tapering. Analyses revealed 3 major themes. First, owing to dynamic changes in patients' social relationships, emotional state, and health status, patients' pain and their perceived need for opioids fluctuate daily; this finding may conflict with recommendations to taper by a certain amount each month. Second, tapering requires substantial patient effort across multiple domains of patients' everyday lives; patients discuss this effort superficially, if at all, with clinicians. Third, patients use a variety of strategies to manage the tapering process (eg, keeping an opioid stash, timing opioid consumption based on planned activities). Recommendations for promoting productive tapering discussions include understanding the social and emotional dynamics likely to impact patients' tapering, addressing patient fears, focusing on patients' best interests, providing anticipatory guidance about tapering, and developing an individualized tapering plan that can be adjusted based on patient response. Perspective: This study used interview and focus group data to characterize patients' experiences with opioid tapering and identify communication strategies that are likely to foster productive, patient-centered discussions of opioid tapering. Findings will inform further research on tapering and help primary care clinicians to address this important, often challenging topic.
Copyright © 2018 the American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic pain; opioid analgesics; opioid tapering; patient–physician relations; primary care; qualitative research; theoretical models

Year:  2018        PMID: 30243859      PMCID: PMC6349552          DOI: 10.1016/j.jpain.2018.09.001

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  22 in total

1.  The patient-provider relationship in chronic pain care: providers' perspectives.

Authors:  Marianne S Matthias; Amy L Parpart; Kathryn A Nyland; Monica A Huffman; Dawana L Stubbs; Christy Sargent; Matthew J Bair
Journal:  Pain Med       Date:  2010-11       Impact factor: 3.750

Review 2.  Tapering Long-term Opioid Therapy in Chronic Noncancer Pain: Evidence and Recommendations for Everyday Practice.

Authors:  Chantal Berna; Ronald J Kulich; James P Rathmell
Journal:  Mayo Clin Proc       Date:  2015-06       Impact factor: 7.616

3.  Doctors and patients in pain: Conflict and collaboration in opioid prescription in primary care.

Authors:  Angela Y Esquibel; Jeffrey Borkan
Journal:  Pain       Date:  2014-09-28       Impact factor: 6.961

4.  Communicating about opioids for chronic pain: a qualitative study of patient attributions and the influence of the patient-physician relationship.

Authors:  M S Matthias; E E Krebs; A A Bergman; J M Coffing; M J Bair
Journal:  Eur J Pain       Date:  2013-11-25       Impact factor: 3.931

5.  The prescribed opioids difficulties scale: a patient-centered assessment of problems and concerns.

Authors:  Caleb J Banta-Green; Michael Von Korff; Mark D Sullivan; Joseph O Merrill; Suzanne R Doyle; Kathleen Saunders
Journal:  Clin J Pain       Date:  2010 Jul-Aug       Impact factor: 3.442

6.  Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study.

Authors:  Jennifer Brennan Braden; Ming-Yu Fan; Mark J Edlund; Bradley C Martin; Andrea DeVries; Mark D Sullivan
Journal:  J Pain       Date:  2008-07-26       Impact factor: 5.820

7.  Development and validation of the Current Opioid Misuse Measure.

Authors:  Stephen F Butler; Simon H Budman; Kathrine C Fernandez; Brian Houle; Christine Benoit; Nathaniel Katz; Robert N Jamison
Journal:  Pain       Date:  2007-05-09       Impact factor: 6.961

8.  "They don't want anything to do with you": patient views of primary care management of chronic pain.

Authors:  Carole C Upshur; Gonzalo Bacigalupe; Roger Luckmann
Journal:  Pain Med       Date:  2010-10-01       Impact factor: 3.750

9.  Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference.

Authors:  Erin E Krebs; Karl A Lorenz; Matthew J Bair; Teresa M Damush; Jingwei Wu; Jason M Sutherland; Steven M Asch; Kurt Kroenke
Journal:  J Gen Intern Med       Date:  2009-05-06       Impact factor: 5.128

10.  Dread and the disvalue of future pain.

Authors:  Giles W Story; Ivaylo Vlaev; Ben Seymour; Joel S Winston; Ara Darzi; Raymond J Dolan
Journal:  PLoS Comput Biol       Date:  2013-11-21       Impact factor: 4.475

View more
  16 in total

1.  Managing Chronic Pain in an Opioid Crisis: What Is the Role of Shared Decision-Making?

Authors:  Marianne S Matthias; Tasneem L Talib; Monica A Huffman
Journal:  Health Commun       Date:  2019-06-10

2.  Role of Rehabilitation in Opioid Tapering: A Scoping Review.

Authors:  Miranda Wiens; Devon Jarrett; Alissa Settimi; Courtney White; Zachary Hollingham; Tara Packham
Journal:  Physiother Can       Date:  2021-06-07       Impact factor: 1.037

Review 3.  Best Practices, Research Gaps, and Future Priorities to Support Tapering Patients on Long-Term Opioid Therapy for Chronic Non-Cancer Pain in Outpatient Settings.

Authors:  Robert Chuck Rich; Roger Chou; Edward R Mariano; Anna Legreid Dopp; Rebecca Sullenger; Helen Burstin
Journal:  NAM Perspect       Date:  2020-08-10

4.  Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan Disenrollment.

Authors:  Ingrid A Binswanger; Susan M Shetterly; Stanley Xu; Komal J Narwaney; David L McClure; Deborah J Rinehart; Anh P Nguyen; Jason M Glanz
Journal:  JAMA Netw Open       Date:  2022-10-03

5.  How opioid prescribing policies influence primary care clinicians' treatment decisions and conversations with patients with chronic pain.

Authors:  Elizabeth C Danielson; Christopher A Harle; Sarah M Downs; Laura Militello; Olena Mazurenko
Journal:  J Opioid Manag       Date:  2021 Nov-Dec

6.  Assessing the effectiveness of a narrative-based patient education video for promoting opioid tapering.

Authors:  Bo Feng; Yining Z Malloch; Richard L Kravitz; Susan Verba; Ana-Maria Iosif; George Slavik; Stephen G Henry
Journal:  Patient Educ Couns       Date:  2020-09-01

7.  Mechanisms, diagnosis, prevention and management of perioperative opioid-induced hyperalgesia.

Authors:  Sylvia H Wilson; Kevin M Hellman; Dominika James; Adam C Adler; Arvind Chandrakantan
Journal:  Pain Manag       Date:  2021-03-29

8.  Collaboration between adult patients and practitioners when making decisions about prescribing opioid medicines for chronic non-cancer pain in primary care: a scoping review.

Authors:  Nirlas Shantilal Bathia; Robyn E McAskill; Jennie E Hancox; Roger D Knaggs
Journal:  Br J Pain       Date:  2021-06-23

9.  The story vs the storyteller: Factors associated with the effectiveness of brief video-recorded patient stories for promoting opioid tapering.

Authors:  Stephen G Henry; Bo Feng; Susan Verba; Richard L Kravitz; Ana-Maria Iosif
Journal:  Health Expect       Date:  2021-04-09       Impact factor: 3.318

10.  Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids.

Authors:  Alicia Agnoli; Guibo Xing; Daniel J Tancredi; Elizabeth Magnan; Anthony Jerant; Joshua J Fenton
Journal:  JAMA       Date:  2021-08-03       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.